14-99174415-G-C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_138576.4(BCL11B):c.2421C>G(p.Asn807Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_138576.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P
- immunodeficiency 49Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_138576.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BCL11B | NM_138576.4 | MANE Select | c.2421C>G | p.Asn807Lys | missense | Exon 4 of 4 | NP_612808.1 | ||
| BCL11B | NM_001282237.2 | c.2418C>G | p.Asn806Lys | missense | Exon 4 of 4 | NP_001269166.1 | |||
| BCL11B | NM_022898.3 | c.2208C>G | p.Asn736Lys | missense | Exon 3 of 3 | NP_075049.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BCL11B | ENST00000357195.8 | TSL:1 MANE Select | c.2421C>G | p.Asn807Lys | missense | Exon 4 of 4 | ENSP00000349723.3 | ||
| BCL11B | ENST00000345514.2 | TSL:1 | c.2208C>G | p.Asn736Lys | missense | Exon 3 of 3 | ENSP00000280435.6 | ||
| BCL11B | ENST00000443726.2 | TSL:5 | c.1839C>G | p.Asn613Lys | missense | Exon 2 of 2 | ENSP00000387419.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities Pathogenic:3
The heterozygous p.Glu879Asp variant in BCL11B was identified by our study in 1 individual with intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities (PMID: 29985992). Trio genome analysis showed this variant to be de novo in 1 individual. This variant was absent from large population studies. The p.Asn807Lys variant is located in a region of BCL11B that is essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 29985992). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS2, PM2, PM1_supporting (Richards 2015).
Immunodeficiency 49 Pathogenic:1
not provided Pathogenic:1
The N807K variant in the BCL11B gene has been reported previously as a de novo variant in a child with developmental delay, dysmorphic facial features, dental anomalies, feeding anomalies, and low T-cell receptor excision circle (TREC) analysis at birth (Lessel et al., 2018). The variant is not observed in large population cohorts (Lek et al., 2016). The N807K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. We interpret N807K as a pathogenic variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at